Abstract
Background
Free fatty acids (FFAs) are established risk factors for various cardiovascular and metabolic disorders. Elevated FFAs can trigger inflammatory response, which may be associated with the occurrence of acute respiratory distress syndrome (ARDS) in cardiac surgery. In this prospective study, we aimed to investigate the association between circulating FFA and the incidence of ARDS, as well as the length of ICU stay, in patients undergoing off-pump coronary artery bypass grafting (CABG).
Methods
We conducted a single-center, prospective, observational study among patients undergoing off-pump CABG. The primary endpoint was the occurrence of ARDS within 6 days after off-pump CABG. Serum FFA were measured at baseline and 24 h post-procedure, and the difference (Δ-FFA) was calculated.
Results
A total of 180 patients were included in the primary analysis. The median FFA was 2.3 mmol/L (quartile 1 [Q1]–Q3, 1.4–3.2) at baseline and 1.5 mmol/L (Q1–Q3, 0.9–2.3) 24 h after CABG, with a Δ-FFA of 0.6 mmol/L (Q1–Q3, -0.1 to 1.6). Patients with elevated Δ-FFA levels had a significantly higher ARDS occurrence (55.6% vs. 22.2%; P < 0.001). Elevated Δ-FFA after off-pump CABG correlated with a significantly lower PaO2/FiO2 ratio, prolonged mechanical ventilation, and extended length of ICU stay. The area under the curve (AUC) of Δ-FFA for predicting ARDS (AUC, 0.758; 95% confidence interval, 0.686–0.831) significantly exceeded the AUC of postoperative FFA (AUC, 0.708; 95% CI 0.628–0.788; P < 0.001).
Conclusions
Elevated Δ-FFA levels correlated with ARDS following off-pump CABG. Monitoring FFA may assist in identifying high-risk patients for ARDS, facilitating timely interventions to improve clinical outcomes.
Similar content being viewed by others
Data Availability
All data generated from this study including supporting information and Raw data are available from the corresponding author on reasonable request.
References
Meyer NJ, Gattinoni L, Calfee CS (2021) Acute respiratory distress syndrome. Lancet 398(10300):622–637
Yadav H, Thompson BT, Gajic O (2017) Is acute respiratory distress syndrome a preventable disease? Am J Resp Crit Care 195(6):725–736
Stephens RS, Shah AS, Whitman GJR (2013) Lung injury and acute respiratory distress syndrome after cardiac surgery. Ann Thorac Surg 95(3):1122–1129
Rong LQ, Di Franco A, Gaudino M (2016) Acute respiratory distress syndrome after cardiac surgery. J Thorac Dis 8(10):E1177–E1186
Asimakopoulos G, Taylor KM, Smith PL, Ratnatunga CP (1999) Prevalence of acute respiratory distress syndrome after cardiac surgery. J Thorac Cardiov Sur 117(3):620–621
Leviner DB, Torregrossa G, Puskas JD (2018) Incomplete revascularization: what the surgeon needs to know. Ann Cardiothorac Sur 7(4):463–469
Ibanez B, Heusch G, Ovize M, Van de Werf F (2015) Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol 65(14):1455–1471
Murashige D, Jang C, Neinast M, Edwards JJ, Cowan A, Hyman MC, Rabinowitz JD, Frankel DS, Arany Z (2020) Comprehensive quantification of fuel use by the failing and nonfailing human heart. Science 370(6514):364–368
Gaba P, Gersh BJ, Ali ZA, Moses JW, Stone GW (2021) Complete versus incomplete coronary revascularization: definitions, assessment and outcomes. Nat Rev Cardiol 18(3):155–168
Michalopoulos A, Tzelepis G, Dafni U, Geroulanos S (1999) Determinants of hospital mortality after coronary artery bypass grafting. Chest 115(6):1598–1603
Mozaffarian D (2007) Free fatty acids, cardiovascular mortality, and cardiometabolic stress. Eur Heart J 28(22):2699–2700
Henderson GC (2021) Plasma free fatty acid concentration as a modifiable risk factor for metabolic disease. Nutrients 13(8):2590
Li M, van Esch BCAM, Wagenaar GTM, Garssen J, Folkerts G, Henricks PAJ (2018) Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells. Eur J Pharmacol 831:52–59
Yin J, Peng Y, Wu J, Wang Y, Yao L (2014) Toll-like receptor 2/4 links to free fatty acid-induced inflammation and beta-cell dysfunction. J Leukoc Biol 95(1):47–52
Lu P, Lu XH, Li B, Wang CF, Wang XF, Ji YM, Liu ZY, Li XY, Yi CL, Song MJ, Wang XW (2022) High-sensitivity cardiac troponin t in prediction and diagnosis of early postoperative hypoxemia after off-pump coronary artery bypass grafting. J Cardiovasc Dev Dis 9(12):416
Montes FR, Maldonado JD, Paez S, Ariza F (2004) Off-pump versus on-pump coronary artery bypass surgery and postoperative pulmonary dysfunction. J Cardiothor Vasc An 18(6):698–703
Chiarenza F, Tsoutsouras T, Cassisi C, Santonocito C, Gerry S, Astuto M, George S, Sanfilippo F (2019) The effects of on-pump and off-pump coronary artery bypass surgery on respiratory function in the early postoperative period. J Intensive Care Med 34(2):126–132
Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS, Force ADT (2012) Acute respiratory distress syndrome the berlin definition. Jama-J Am Med Assoc 307(23):2526–2533
Yuan DS, Xu N, Song Y, Zhang Z, Xu JJ, Liu ZY, Tang XF, Han YL, Chen Y, Zhang YZ, Zhu P, Guo XG, Wang ZF, Liu R, Wang QS, Yao Y, Feng YQ, Zhao XY, Yuan JQ (2023) Association between free fatty acids and cardiometabolic risk in coronary artery disease: results from the PROMISE study. J Clin Endocr Metab 109:125–134
Shi S, Gao Y, Wang LM, Liu J, Yuan ZX, Yu M (2015) Elevated free fatty acid level is a risk factor for early postoperative hypoxemia after on-pump coronary artery bypass grafting: association with endothelial activation. J Cardiothorac Surg 10:122
Han FY, Hu F, Wang T, Zhou W, Zhu LJ, Huang X, Bao HH, Cheng XS (2022) Association between basal metabolic rate and all-cause mortality in a prospective cohort of southern chinese adults. Front Physiol 12:790347
Agudelo CW, Samaha G, Garcia-Arcos I (2020) Alveolar lipids in pulmonary disease. A review. Lipids Health Dis 19(1):122
Halbirk M, Norrelund H, Moller N, Schmitz O, Gotzsche L, Nielsen R, Nielsen-Kudsk JE, Nielsen SS, Nielsen TT, Eiskjaer H, Botker HE, Wiggers H (2010) Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function. Am J Physiol-Heart C 299(4):H1220–H1225
Manolis AA, Manolis TA, Melita H, Mikhailidis DP, Manolis AS (2022) Low serum albumin: A neglected predictor in patients with cardiovascular disease. Eur J Intern Med 102:24–39
Nielsen R, Moller N, Gormsen LC, Tolbod LP, Hansson NH, Sorensen J, Harms HJ, Frokiaer J, Eiskjaer H, Jespersen NR, Mellemkjaer S, Lassen TR, Pryds K, Botker HE, Wiggers H (2019) Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients. Circulation 139(18):2129–2141
Saddik M, Lopaschuk GD (1992) Myocardial triglyceride turnover during reperfusion of isolated rat hearts subjected to a transient period of global ischemia. J Biol Chem 267(6):3825–3831
Kolwicz SC Jr (2021) Ketone body metabolism in the ischemic heart. Front Cardiovasc Med 8:789458
Sanfilippo F, Palumbo GJ, Bignami E, Pavesi M, Ranucci M, Scolletta S, Pelosi P, Astuto M (2022) Acute respiratory distress syndrome in the perioperative period of cardiac surgery: predictors diagnosis, prognosis, management options, and future directions. J Cardiothorac Vasc Anesth 36(4):1169–1179
Silva PL, Pelosi P, Rocco PRM (2020) Personalized pharmacological therapy for ARDS: a light at the end of the tunnel. Expert Opin Investig Drugs 29(1):49–61
Sadee W, Wang D, Hartmann K, Toland AE (2023) Pharmacogenomics: driving personalized medicine. Pharmacol Rev 75(4):789–814
Bourgonje AR, Kloska D, Grochot-Przeczek A, Feelisch M, Cuadrado A, van Goor H (2023) Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1alpha and NRF2 as therapeutic targets. Redox Biol 60:102603
Asensio M, Herraez E, Macias RIR, Lozano E, Munoz-Bellvis L, Sanchez-Vicente L, Morente-Carrasco A, Marin JJG, Briz O (2023) Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma. Biochem Pharmacol 214:115681
Makimura H, Stanley TL, Suresh C, De Sousa-Coelho AL, Frontera WR, Syu S, Braun LR, Looby SE, Feldpausch MN, Torriani M, Lee H, Patti ME, Grinspoon SK (2016) Metabolic effects of long-term reduction in free fatty acids with acipimox in obesity: a randomized trial. J Clin Endocrinol Metab 101(3):1123–1133
Liang H, Tantiwong P, Sriwijitkamol A, Shanmugasundaram K, Mohan S, Espinoza S, Defronzo RA, Dube JJ, Musi N (2013) Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects. J Physiol 591(11):2897–2909
Kintscher U, Foryst-Ludwig A, Haemmerle G, Zechner R (2020) The role of adipose triglyceride lipase and cytosolic lipolysis in cardiac function and heart failure. Cell Rep Med 1(1):100001
Acknowledgements
None.
Funding
This research was supported by National Natural Science Foundation of China (No. 81573234), National Natural Science Foundation of China (No. 81773445), Key Project of Taizhou School of Clinical Medicine (No. TZKY20220304), Key Project of Jiangsu Commission of Health (No. ZDA2020004), and Ili&Jiangsu Joint Institute of Health (No. YL2022MS04).
Author information
Authors and Affiliations
Contributions
M.S. and X.W. conceived and designed the study. P.L., J.F., X.Y., Z.L., Y.Q., Z.S., and Z.W. gathered the data. P.L., C.Y., and M.S. performed statistical analyses. P.L., J.F., X.L., and X.W. wrote the first draft of the manuscript. P.L., M.S., and X.W. made critical revision of the manuscript for key intellectual components. All authors provided approval of the final version of the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Ethical Approval
Ethical approval for this study was obtained from The First Affiliated Hospital with Nanjing Medical University (protocol code 2023-SR-513, 2023-03-23).
Consent to Participate
Informed consent was obtained for all participants in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lu, P., Fan, J., Li, X. et al. Serum Free Fatty Acid Concentration Predicts ARDS after Off-Pump CABG: A Prospective Observational Study. Lung (2024). https://doi.org/10.1007/s00408-024-00704-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00408-024-00704-3